Deep Track Capital, LP
CIK 1856083
13F filing for Q2 2026・No. 741
- Holdings
- US$6.87B
- Quarter change
- +US$746.91M
- Entries
- 67
- Net bought (estimate)
- +US$647.7M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 18
- Sold out 14
- Cut 15
- Added 22
- Corporate actions 0
- Unchanged 11
Largest holdings
66 stocks worth US$6.79B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| GHGUARDANT HEALTH INCCOM | Added | 3,393,312 | US$509.1M | 7.50% |
| IMMUNOVANT INCCOM | Cut | 9,341,151 | US$359.91M | 5.30% |
| STRUCTURE THERAPEUTICS INCSPONSORED ADS | Added | 4,740,072 | US$254.4M | 3.75% |
| PCVXVAXCYTE INCCOM | Unchanged | 4,300,000 | US$249.96M | 3.68% |
| ALNYALNYLAM PHARMACEUTICALS INCCOM | New | 825,000 | US$248.35M | 3.66% |
| VERADERMICS INCCOMMON STOCK | Added | 2,000,000 | US$245.88M | 3.62% |
| TARSUS PHARMACEUTICALS INCCOM | Added | 3,666,768 | US$230.79M | 3.40% |
| NUVLNUVALENT INCCOM | Added | 1,783,322 | US$220.24M | 3.24% |
| ALKSALKERMES PLCSHS | Added | 4,000,000 | US$209.58M | 3.09% |
| OCULAR THERAPEUTIX INCCOM | Unchanged | 19,686,282 | US$193.32M | 2.85% |
Sign in (free) to see its 50 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.